11/18/2024 7:35 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 6:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 7:07 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 3:20 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 3:10 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
08/14/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form PRE 14A | |
07/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form EFFECT | |
07/24/2024 4:11 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 424B3 | |
07/18/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/16/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 10:11 AM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4/A | |
06/26/2024 8:15 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 3:15 PM | DONG-A ST CO., LTD (Filed by) NeuroBo Pharmaceuticals, Inc. (Subject) NeuroBo Pharmaceuticals (Subject)
| Form SC 13D/A | |
06/25/2024 3:16 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 424B5 | |
06/25/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/24/2024 5:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) Tursi James Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) STRICKLAND D GORDON (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | Glickman Mark A (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | KOVEN ANDREW I (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | GROVES JASON L (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) Salsbury Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 8:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 7:05 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 7:41 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form DEF 14A | |
04/30/2024 7:42 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form ARS | |
04/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form EFFECT | |
04/17/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:30 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 8:20 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) Woodworth Marshall H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Trump said you could learn something from this man (Ad) Early Warning: A Deep Crack Is Forming In The US Economy
Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. |
03/04/2024 6:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:52 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/01/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/18/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 7:45 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 8:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2023 8:03 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/07/2023 8:20 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/04/2023 4:12 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) Tursi James Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |